Erica Mann

Erica L.
Mann is currently Director at Firmenich SA, Independent Non-Executive Director at ALS Ltd. since 2024, Independent Director at DSM-Firmenich AG since 2019, and Independent Director at Kenvue, Inc. starting in 2025.
Former positions include Chairman-Elect at World Self Medication Industry (2013-2014), Chairman at World Self-Medication Industry Association (2011-2018), Non-Executive Director at Soho Flordis International Pty Ltd. (2018-2019), Senior VP-Nutrition & Managing Director-ANZ at Wyeth South Africa (Pty) Ltd. (2003-2009), Independent Non-Executive Director at Perrigo Co. Plc (2019-2024), Independent Non-Executive Director at Blackmores Ltd. (2021-2023), Independent Director at Kellanova (2019-2025), Principal at Johnson & Johnson, Principal at Eli Lilly & Co., Head-Consumer Health Division at Bayer AG (2016-2018), President-Consumer Care Division at Bayer Healthcare LLC (2015), Head-Bayer Health Cares Consumer Care Division at Bayer HealthCare AG, Principal at Lederle Laboratories, Member-Management Board at Bayer (Schweiz) AG (2016-2018),.
Principal at International Association of Infant Food Manufacturers, President-Consumer Health Division at Bayer Group (2011-2018), Member-Supervisory Board at DSM BV (2019-2023), and President & General Manager-Nutrition at Pfizer Inc. (2009-2011).
Education includes undergraduate degrees from the University of Johannesburg and the Institute of Marketing Management.